Ticker > Company >

Lupin share price

Lupin Ltd.

NSE: LUPIN BSE: 500257 SECTOR: Pharmaceuticals & Drugs  296k   870   152

2004.85
-17.30 (-0.86%)
BSE: 13 Jun 04:01 PM

Price Summary

Today's High

₹ 2017.65

Today's Low

₹ 1981.75

52 Week High

₹ 2403.45

52 Week Low

₹ 1531.15

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

91560.59 Cr.

Enterprise Value

91440.08 Cr.

No. of Shares

45.67 Cr.

P/E

23.05

P/B

3.77

Face Value

₹ 2

Div. Yield

0.6 %

Book Value (TTM)

₹  531.61

CASH

138.64 Cr.

DEBT

18.13 Cr.

Promoter Holding

46.92 %

EPS (TTM)

₹  86.99

Sales Growth

30.27%

ROE

12 %

ROCE

14.33%

Profit Growth

447.05 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Lupin Ltd.

Molnulup Respira endeavour maxter pinnacle blue eyes femina midvision CVN ONDERO Piclin Menoctyl Sucramal O Pyridium Distaclor Vilfuro-G

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year30.27%
3 Year9.88%
5 Year5.25%

Profit Growth

1 Year447.04%
3 Year22.72%
5 Year8.61%

ROE%

1 Year12%
3 Year4.44%
5 Year4.93%

ROCE %

1 Year14.33%
3 Year5.72%
5 Year6.55%

Debt/Equity

0.0009

Price to Cash Flow

36.56

Interest Cover Ratio

50.4177

CFO/PAT (5 Yr. Avg.)

1.81119731268013

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 46.92 0.00
Dec 2024 46.95 0.00
Sep 2024 46.96 0.00
Jun 2024 46.98 0.00
Mar 2024 47.01 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 22.7186668112775% for the Past 3 years.
  • The company has significantly decreased its debt by 595.33 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 50.4177.
  • Company’s PEG ratio is 0.051649032777878.
  • The company has an efficient Cash Conversion Cycle of -1.21610000000001 days.
  • Company has a healthy liquidity position with current ratio of 2.5066.
  • The company has a good cash flow management; CFO/PAT stands at 1.81119731268013.

 Limitations

  • The company has shown a poor revenue growth of 9.87780953620883% for the Past 3 years.
  • Company has a poor ROE of 4.43752488278403% over the past 3 years.
  • Company has contingent liabilities of 4029.78 Cr.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 3395.88 4167.63 4106.2 4208 4485.67
Total Expenditure 2695.53 2968.82 2991.45 2796.95 2739.54
Operating Profit 700.35 1198.81 1114.75 1411.05 1746.13
Other Income 31.34 39.08 32.62 55.3 48.79
Interest 13.49 13.55 17.55 19.55 33.85
Depreciation 290.04 141.42 145.77 152.52 207.98
Exceptional Items 0 0 0 -77.22 0
Profit Before Tax 428.16 1082.92 984.05 1217.06 1553.09
Tax 44.08 193.74 176.29 232.39 261.74
Profit After Tax 384.08 889.18 807.76 984.67 1291.35
Adjusted EPS (Rs) 8.43 19.5 17.71 21.58 28.28

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 11025.66 11055.93 11771.67 11258.83 14666.5
Total Expenditure 9118.05 9011.87 11566.69 10294.93 11227.12
Operating Profit 1907.61 2044.06 204.98 963.9 3439.38
Other Income 475.19 129.09 221.15 210.02 126.41
Interest 52.59 40.62 73.47 98.44 56.35
Depreciation 518.75 502.83 514.19 548.34 724.75
Exceptional Items -759.21 0 0 0 0
Profit Before Tax 1052.25 1629.7 -161.53 527.14 2784.69
Tax 324.7 371.08 27.17 101.93 458.6
Net Profit 727.55 1258.62 -188.7 425.21 2326.09
Adjusted EPS (Rs.) 16.06 27.74 -4.15 9.35 51.04

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 90.6 90.74 90.9 91 91.14
Total Reserves 17382.6 18474.83 18059.29 18320.86 20511.95
Borrowings 0.31 0.15 0 0 0
Other N/C liabilities 651.2 707.01 625.27 643.96 625.83
Current liabilities 2555.79 2585.83 3537.91 3627.85 3646.42
Total Liabilities 20680.5 21858.56 22313.37 22683.67 24922.86
Assets
Net Block 3513.88 3638.83 3690.18 4021.93 4113.17
Capital WIP 694.63 795.83 773.74 737.99 411.12
Intangible WIP 127.37 155.03 173.7 188.6 34.71
Investments 5126.7 7241.59 8688.69 9534.56 10771.82
Loans & Advances 376.38 399.62 537.04 603.86 231.19
Other N/C Assets 3.03 10.29 12.2 25.81 220.67
Current Assets 10838.51 9617.37 8437.82 7570.92 9140.18
Total Assets 20680.5 21858.56 22313.37 22683.67 24922.86
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 1052.25 1629.7 -161.53 527.14 2784.69
Adjustment 718.54 487.06 449.36 583.79 771.3
Changes in Assets & Liabilities 834.62 -118.04 -284.97 809.86 -905.21
Tax Paid -385.92 -428.64 148.17 -126.8 -146.65
Operating Cash Flow 2219.49 1570.08 151.03 1793.99 2504.13
Investing Cash Flow -739.56 -2507.52 -371.79 -1269.17 -1599.02
Financing Cash Flow -367.85 -53.17 102.45 -498.26 -867.07
Net Cash Flow 1112.08 -990.61 -118.31 26.56 38.04

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 47.01 46.98 46.96 46.95 46.92
anuja gupta 0.16 0.16 0.16 0.16 0.16
desh bandhu gupta huf 0.14 0.14 0.14 0.14 0.14
kavita gupta 0.04 0.04 0.04 0.04 0.04
lupin investments pvt ltd... 45.47 45.45 45.42 45.41 45.38
manju d gupta 0.85 0.85 0.85 0.85 0.85
neel deshbandhu gupta 0.01 0.01 0.01 0.01 0.01
nilesh d gupta 0.20 0.20 0.20 0.20 0.20
richa gupta 0.05 0.05 0.05 0.05 0.05
veda nilesh gupta 0.02 0.02 0.02 0.02 0.02
vinita gupta 0.07 0.07 0.07 0.07 0.07
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 52.99 53.02 53.04 53.05 53.08
axis mutual fund trustee ... - - 1.30 1.38 1.54
hdfc life insurance compa... 1.37 1.33 1.38 1.32 1.31
hdfc trustee company ltd-... 3.11 3.60 3.37 3.36 3.22
icici prudential value di... 4.31 3.46 2.54 2.61 2.63
investor education and pr... 0.17 0.17 - - 0.17
life insurance corporatio... 5.87 5.13 2.89 2.27 2.05
llp - 0.12 0.05 0.03 0.03
mirae asset large and mid... 1.49 1.53 1.02 1.20 1.42
nippon life india trustee... 1.87 1.86 1.81 1.90 1.88
nps trust-a/c hdfc pensio... - - - - 1.42
sbi life insurance co. lt... - - - - 1.07
sbi long term equity fund... 1.14 1.17 1.60 1.63 1.62
investor education and pr... - - 0.16 0.17 -
nps trust- a/c hdfc pensi... - - - 1.31 -
sbi life insurance compan... - - 1.04 1.05 -

Annual Reports

Title Action
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY ACTION
Credit ICRA
Credit ICRA
Credit ICRA
TYPE AGENCY ACTION
Research BOB Capital Market
Research Geojit
Research Report By:
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research HDFC Securities
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research Motilal Oswal
Research Prabhudas Lilladhar
Research ICICI Securities Limited
Research Nirmal Bang Institutional
Research HDFC Securities
Research BOB Capital Markets Ltd.

Concalls & Presentations

TYPE QUARTER ACTION
Concall Q4FY24
Concall Q4FY22
Concall Q4FY21
Concall Q3FY25
Concall Q3FY24
Concall Q3FY23
Concall Q3FY22
Concall Q3FY21
Concall Q3 FY20
Concall Q2FY24
Concall Q2FY23
Concall Q2FY22
Concall Q1FY25
Concall Q1FY24
Concall Q1FY22
Concall Q1FY21
TYPE QUARTER ACTION
Presentation Q4FY25
Presentation Q4FY24
Presentation Q4FY21
Presentation Q3FY24
Presentation Q3FY23
Presentation Q3FY22
Presentation Q2FY24
Presentation Q2FY22
Presentation Q2FY21
Presentation Q1FY25
Presentation Q1FY24
Presentation Q1FY22
Presentation Q1FY21

Company News

Lupin Stock Price Analysis and Quick Research Report. Is Lupin an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Lupin and its performance over the period of time. Lupin stock price today is Rs 1999.6.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Lupin cash from the operating activity was Rs 2504.13 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Lupin has a Debt to Equity ratio of 0.0009 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Lupin , the EPS growth was 446.2029 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Lupin has OPM of 23.4505846657348 % which is a good sign for profitability.
     
  • ROE: Lupin have a average ROE of 12.0045 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Lupin is Rs 1999.6. One can use valuation calculators of ticker to know if Lupin share price is undervalued or overvalued.
Last Updated on:
Brief about Lupin
X